MichaelThomasPulleyMDPhD

Neurology • Jacksonville, FL

Headache, Neurophysiology

Associate Professor, Neurology, University of Florida College of Medicine

Join to view full profile

Dr. Pulley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pulley's full profile

Already have an account?

Office
580 W 8th St
UFJP Neurology
Jacksonville, FL 32209
Phone+1 904-244-3960

Fax+1 904-244-3425

Education & Training

Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1997 - 1998
Duke University HospitalResidency, Neurology, 1994 - 1997
Sinai Hospital of BaltimoreInternship, Internal Medicine, 1993 - 1994
University of Maryland School of MedicineClass of 1993

Certifications & Licensure

FL State Medical License 1998 - 2025
GA State Medical License 1998 - 2019
MD State Medical License 1998 - 1999
NC State Medical License 1994 - 1999
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology

Clinical Trials

Efficacy of Methotrexate in Myasthenia Gravis Start of enrollment: 2009 Apr 01
Completed
Phase 2
International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis Start of enrollment: 2015 Aug 01
Completed
Phase 2
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis Start of enrollment: 2024 Jan 24
Recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

117 citations
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui-Chien Kuo
The Lancet. Neurology. 2019-03-01
23 citations
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized T...
Richard J. Barohn, Byron J. Gajewski, Mamatha Pasnoor, Alexandra R. Brown, Laura Herbelin
JAMA Neurology. 2021-01-01
180 citations
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric
The Lancet. Neurology. 2021-07-01

Press Mentions

Clinical Effects of the Self-Administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia GravisFebruary 17th, 2020
'Us Against ALS': Jacksonville Lawman, Family Make Every Minute Count; CEOs Join in Fundraiser for NonprofitJuly 19th, 2021